期刊文献+

可降解水凝胶栓塞动脉瘤的实验研究 被引量:2

The study of chitosan/glycerophosphate(C/GP) hydrogel as the embolism material of aneurysms
原文传递
导出
摘要 目的探讨壳聚糖/甘油磷酸钠水凝胶作为动脉瘤栓塞材料的可行性。方法配制2%壳聚糖与56%甘油磷酸钠溶液,不同比例混合,测定混合液pH、37℃成胶时间及力学强度,选择最佳比例。体外栓塞动脉瘤模型,评价导管内操控性;通过兔耳中动脉栓塞评价组织相容性。最终栓塞兔动脉瘤模型。结果当壳聚糖/甘油磷酸钠在7:1时,pH值为7.28,成胶时间为(260±18)S,力学强度可达14kPa。体外动脉瘤模型栓塞见壳聚糖/甘油磷酸钠水凝胶可通过导管在动脉瘤内成胶。兔耳中动脉栓塞后3d,血管周围可见少量炎性细胞浸润,1周时达到高峰,2—3周逐渐消退,4—8周形成肉芽组织,并可见壳聚糖凝胶部分降解。兔动脉瘤栓塞术中见动脉瘤不显影,术后3d病理见动脉瘤被凝胶栓塞,内膜细胞形态正常,动脉壁内未见明显炎性细胞浸润。结论短期观察,壳聚糖/甘油磷酸钠水凝胶可用于动脉瘤栓塞。 Objective To evaluate the feasibility of injectable thermosetting chitosan/ glycerophosphate(C/GP) hydrogel as the embolism material of aneurysms. Method 2% chitosan solution and 56% glycerophosphate solution were mixed in different volume ratios. The pH, colloidization time in 37℃ and mechanic strength of the mixed solution were detected respectively to determine the best ratio. The intracatheter operation of the C/GP hydrogel by embolizing aneurysm models was evaluated. The C/GP hydrogel histocompatibility was evaluated by embolizing rabbit ear arteries. Finally, we embolized rabbit aneurysm models with this C/GP gel. Results When the ratio of C/GP was 7 : 1 at pH 7. 28, the colloidization time was (260 ± 18 ) seconds and the mechanic strength chould reach 14 kPa. In the experiment of embolizing aneurysm models in vitro, the C/GP gel could arrive in aneurysms through catheter and reach solid state. In the experiment of embolizing rabbit ear arteries, the modest inflammation was observed. This effect peak was found in 1 week, and gradually resolution in 2 - 3 weeks. In 4 - 8 weeks, granulation tissue and slight degradation of C/GP hydrogel could be observed. In the embolism operation of rabbit aneurysms, the aneurysms were disappeared in angiography. In the HE stain slice 3 days after operation, the C/GP hydrogcl in aneurysm caves and normal endomembrane cells were observed. There was no significant flame cell in aneurysm walls. Conclusions In short term view, C/GP hydrogel could be used to embolize aneurysms.
出处 《中华神经外科杂志》 CSCD 北大核心 2009年第1期31-34,共4页 Chinese Journal of Neurosurgery
基金 基金项目:国家自然科学基金资助项目(ISIS:30471768)
关键词 壳聚糖 甘油磷酸钠 水凝胶 动脉瘤 栓塞材料 Chitosan Glycerophosphate Hydrogel Aneurysms Embolism materials
  • 相关文献

参考文献9

  • 1Ribourtout E, Desfaits AC,Salazkin I,et al. Ex vivo gene therapy with adenovirus-mediated transforming growth factor beta 1 expression for endovascular treatment of aneurysm: results in a canine bilateral aneurysm model. J Vasc Surg,2003 ,38 :576-583.
  • 2Ribourtout E, Raymond J. Gene therapy and endovascular treatment of intracranial aneurysms. Stroke,2004,35:786-793.
  • 3梅林,孙洪范,唐丽娜,杨菁,常津,宋存先.血管内微弹簧圈用于基因运载体系[J].中国医学科学院学报,2005,27(2):190-193. 被引量:1
  • 4王东武,杨柳,段小军,李忠,张洪鑫.可注射温固化支架复合异体软骨细胞修复关节软骨缺损的初步研究[J].重庆医学,2006,35(12):1082-1084. 被引量:9
  • 5Chatelet C, Damour O, Domard A. Influence of the degree of acetylation on some biological properties of chitosan films. Biomaterials, 2001,22:261-268.
  • 6Alberto DM, Michael S, Makarand VR. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials,2005, 26:5983-5990.
  • 7Chenite A, Chaput C ,Wang D,el al. Novel injectable neutral solutions of chitosan from biodegradable gels in situ. Biomaterials,2000,21:2155-2161.
  • 8王东武,杨柳,戴刚.可注射C/GP支架的组织相容性及与BMCs的细胞相容性观察[J].重庆医学,2007,36(9):846-848. 被引量:8
  • 9Molinaro G, Leroux JC, Damas J, et al. Biocompatibility of thermosensitive chitosan-based hydrogels: an in vivo experimental approach to injectable biomaterials. Biomaterials, 2002, 23: 2717-2722.

二级参考文献33

共引文献14

同被引文献21

  • 1Murayama Y,Vinuela F,Uihoa A,et al.Nonadhesive liquid embolic agent for cerebral arteriovenous malformation:preliminary histopat hological studies in swine rete mirabile[J].Neurosurgery,1998,43:1164-1175.
  • 2Massoud TF,Vinters HV,Chao KH,et al.Histopathologic characteristics of a chronic arteriovenous malformation in a swine model:preliminary study[J].AJNR Am J Neuroradiol,2000,21:1268-1276.
  • 3Gabriel RA,Kim H,Sidney S,et al.Ten-year detection rate of brain arteriovenous malformations in a large,multiethnic,defined population[J].Stroke,2010,41:21-26.
  • 4Kim H,Pawlikowska L,Chen Y,et al.Brain arteriovenous malformation biology relevant to hemorrhage and implication for therapeutic development[J].Stroke,2009,40 (3 Suppl):S95-S97.
  • 5Bakar B,Oruckaptan HH,Hazer BD,et al.Evaluation of the toxicity of onyx compared with n-butyl 2-cyanoacrylate in the subarachnoid space of a rabbit model:An experimental research[J].Neuroradiology,2010,52:125-134.
  • 6Starke RM,Komotar R J,Otten ML,et al.Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations:outcomes,complications,and predictors of neurologic deficits[J].Stroke,2009,40:2783-2790.
  • 7Chenite A,Chaput C,Wang D,et al.Novel injectable neutral solutions of chitosan form biodegradable gels in situ[J].Biomaterials,2000,21:2155-2161.
  • 8Agarwal P,Rupenthal ID.Injectable implants for the sustained release of protein and peptide drugs[J].Drug Discov Today,2013,18:337-349.
  • 9Wang Y,Xu N,Luo Q,et al.In vivo assessment of chitosan/betaglycerophosphate as a new liquid embolic agent[J].Interv Neuroradiol,2011,17:87-92.
  • 10Han HD,Nam DE,Seo DH,et al.Preparation and biodegradation of thermosensitive chitosan hydrogel as a function of pH and temperature[J].Macromol Res,2004,12:507-511.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部